Literature DB >> 408069

Rh hemolytic disease of the newborn--the disease eradicated by immunology.

A Zipursky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408069     DOI: 10.1097/00003081-197709000-00021

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  5 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

3.  Clinical use of blood, blood components and blood products.

Authors:  M A Blajchman; F A Shepherd; R A Perrault
Journal:  Can Med Assoc J       Date:  1979-07-07       Impact factor: 8.262

4.  Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.

Authors:  Xiaohui Xie; Qiurong Fu; Ziwei Bao; Yi Zhang; Dan Zhou
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

Review 5.  Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.

Authors:  Vinod K Bhutani; Alvin Zipursky; Hannah Blencowe; Rajesh Khanna; Michael Sgro; Finn Ebbesen; Jennifer Bell; Rintaro Mori; Tina M Slusher; Nahed Fahmy; Vinod K Paul; Lizhong Du; Angela A Okolo; Maria-Fernanda de Almeida; Bolajoko O Olusanya; Praveen Kumar; Simon Cousens; Joy E Lawn
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.